Seven Fleet Capital Management LP
CIK
2092021
Location
MOUNTAIN VIEW, CA
Portfolio Value
Small
$177,773,650
Diversification
Diversified
Filing Date
Global Rank
#4,474
/ 8,605
▲ 578
· as of Mar 2026
Top Industry
Biotechnology
92.5%
3Y Alpha vs SPY
+151.3%
Period ended 3 months ago
Filed Jun 4, 2026 · 35d
2 quarters · since Dec 2025
Clone Performance
Feb 2026–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+50.3%
SPY
+10.0%
Annualised alpha
+152.0%
Max drawdown
−10.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
99 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
5.9%
−36.9 pts
Top 5
22.5%
−36.6 pts
Top 10
39.5%
−29.2 pts
HHI
243
Diversified−1,695
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $177,773,650 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | +458,485 | 625,708 | $2,796,914 | |
| CTMX | CytomX Therapeutics, Inc. | +322,500 | 371,398 | $1,745,570 | |
| TNGX | Tango Therapeutics, Inc. | +286,840 | 502,012 | $10,502,091 | |
| SVRA | Savara Inc | +232,926 | 295,688 | $1,614,456 | |
| RLAY | Relay Therapeutics, Inc. | +184,738 | 257,738 | $2,564,493 | |
| AGIO | Agios Pharmaceuticals, Inc. | +177,809 | 209,547 | $7,088,975 | |
| AVTX | Avalo Therapeutics, Inc. | +150,476 | 213,819 | $3,192,317 | |
| CMPS | COMPASS Pathways plc | +118,021 | 158,021 | $873,856 | |
| PHVS | Pharvaris N.V. | +117,389 | 172,731 | $4,879,650 | |
| TYRA | Tyra Biosciences, Inc. | +116,125 | 195,685 | $7,494,735 | |
| VSTM | Verastem, Inc. | +108,260 | 123,400 | $654,020 | |
| LQDA | Liquidia Corp | +96,609 | 187,876 | $7,090,440 | |
| PCVX | Vaxcyte, Inc. | +83,085 | 108,450 | $6,302,029 | |
| KALV | KalVista Pharmaceuticals, Inc. | +80,075 | 128,487 | $2,586,443 | |
| ENTX | Entera Bio Ltd. | +70,224 | 205,542 | $228,151 | |
| ELVN | Enliven Therapeutics, Inc. | +64,077 | 164,030 | $6,429,976 | |
| CLYM | Climb Bio, Inc. | +54,254 | 130,654 | $894,979 | |
| CYTK | Cytokinetics Inc | +50,934 | 61,269 | $4,038,239 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | +39,607 | 54,258 | $4,553,331 | |
| LONA | LeonaBio, Inc. | +36,725 | 164,676 | $1,692,869 | |
| ABVX | Abivax S.A. | +29,553 | 43,052 | $4,793,840 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | +28,937 | 85,687 | $804,600 | |
| MLYS | Mineralys Therapeutics, Inc. | +27,546 | 69,571 | $1,884,678 | |
| TRVI | Trevi Therapeutics, Inc. | +20,039 | 27,149 | $323,887 | |
| GLUE | Monte Rosa Therapeutics, Inc. | +18,530 | 22,530 | $370,618 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
16 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | −1,439,393 | 75,758 | $5,127,301 | |
| GERN | Geron Corp | −353,700 | 424,180 | $632,028 | |
| IKT | Inhibikase Therapeutics, Inc. | −208,048 | 325,600 | $547,008 | |
| PALI | Palisade Bio, Inc. | −114,400 | 213,100 | $372,925 | |
| COGT | Cogent Biosciences, Inc. | −64,700 | 149,399 | $5,750,367 | |
| CMPX | Compass Therapeutics, Inc. | −51,775 | 516,972 | $2,734,781 | |
| XNCR | Xencor Inc | −29,554 | 80,000 | $964,800 | |
| ASMB | Assembly Biosciences, Inc. | −17,615 | 56,147 | $1,558,079 | |
| SLNO | Soleno Therapeutics Inc | −14,309 | 115,770 | $3,875,979 | |
| NKTR | Nektar Therapeutics | −10,700 | 4,300 | $309,385 | |
| NUVL | Nuvalent, Inc. | −10,529 | 2,072 | $212,276 | |
| PTGX | Protagonist Therapeutics, Inc | −4,000 | 4,000 | $421,600 | |
| EOLS | Evolus, Inc. | −3,943 | 78,057 | $320,814 | |
| CELC | Celcuity Inc. | −2,338 | 6,000 | $684,840 | |
| CGEM | Cullinan Therapeutics, Inc. | −1,156 | 1,844 | $26,203 | |
| BEAM | Beam Therapeutics Inc. | −733 | 8,804 | $209,799 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | 2,947,826 | $6,662,086 | |
| ERAS | Erasca, Inc. | 222,468 | $3,599,532 | |
| ROIV | Roivant Sciences Ltd. | 128,168 | $3,550,253 | |
| EPRX | Eupraxia Pharmaceuticals Inc. | 433,515 | $3,138,648 | |
| IDYA | IDEAYA Biosciences, Inc. | 86,283 | $2,874,949 | |
| DMRA | Damora Therapeutics, Inc. | 101,248 | $2,622,323 | |
| DFTX | Definium Therapeutics, Inc. | 99,887 | $1,887,864 | |
| CATX | Perspective Therapeutics, Inc. | 379,082 | $1,580,771 | |
| NERV | Minerva Neurosciences, Inc. | 248,476 | $1,497,067 | |
| ZLAB | Zai Lab Ltd | 77,858 | $1,464,508 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 82,890 | $1,212,680 | |
| AVBP | ArriVent BioPharma, Inc. | 50,252 | $1,159,313 | |
| LRMR | Larimar Therapeutics, Inc. | 256,585 | $1,154,632 | |
| IVA | Inventiva S.A. | 200,141 | $1,110,782 | |
| LPCN | Lipocine Inc. | 124,942 | $998,286 | |
| SYRE | Spyre Therapeutics, Inc. | 19,690 | $993,163 | |
| BCRX | Biocryst Pharmaceuticals Inc | 102,493 | $975,733 | |
| CLDX | Celldex Therapeutics, Inc. | 29,300 | $929,396 | |
| REPL | Replimune Group, Inc. | 120,400 | $921,060 | |
| MAZE | Maze Therapeutics, Inc. | 30,707 | $916,603 | |
| ALKS | Alkermes plc. | 24,170 | $854,651 | |
| ANTX | AN2 Therapeutics, Inc. | 199,701 | $682,977 | |
| DNLI | Denali Therapeutics Inc. | 35,286 | $677,491 | |
| UTHR | UNITED THERAPEUTICS Corp | 1,128 | $668,881 | |
| LLY | ELI LILLY & Co | 720 | $662,234 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TERN | Terns Pharmaceuticals, Inc. | 130,413 | $5,268,685 | |
| EXEL | Exelixis, Inc. | 68,569 | $3,005,379 | |
| BLTE | Belite Bio, Inc | 9,161 | $1,465,393 | |
| DYN | Dyne Therapeutics, Inc. | 70,180 | $1,372,720 | |
| FOLD | AMICUS THERAPEUTICS, INC. | 82,500 | $1,174,800 | |
| ZURA | Zura Bio Ltd | 166,500 | $872,460 | |
| IMUX | Immunic, Inc. | 155,223 | $828,890 | |
| PRAX | Praxis Precision Medicines, Inc. | 2,700 | $795,798 | |
| RLMD | Relmada Therapeutics, Inc. | 154,109 | $744,346 | |
| MBX | MBX Biosciences, Inc. | 18,200 | $574,028 | |
| ZYME | Zymeworks Inc. | 20,600 | $542,398 | |
| VRDN | Viridian Therapeutics, Inc.DE | 14,654 | $456,032 | |
| NRIX | Nurix Therapeutics, Inc. | 20,000 | $379,400 | |
| PLRX | Pliant Therapeutics, Inc. | 276,500 | $337,330 | |
| ACRS | Aclaris Therapeutics, Inc. | 107,419 | $323,331 | |
| VKTX | Viking Therapeutics, Inc. | 6,000 | $211,080 | |
| QURE | uniQure N.V. | 8,742 | $209,196 | |
| ORKA | Oruka Therapeutics, Inc. | 5,240 | $158,824 | |
| NAMS | NewAmsterdam Pharma Co N.V. | 4,000 | $140,320 | |
| ALXO | Alx Oncology Holdings Inc | 117,817 | $133,133 | |
| RGC | Regencell Bioscience Holdings Ltd | 4,400 | $92,400 | |
| TRAW | Traws Pharma, Inc. | 49,260 | $55,663 | |
| VTGN | Vistagen Therapeutics, Inc. | 62,701 | $41,382 | |
| ENTA | Enanta Pharmaceuticals Inc | 2,270 | $35,797 | |
| ELDN | Eledon Pharmaceuticals, Inc. | 6,000 | $9,060 | |
| No positions match the current search. | ||||
99 positions ·
$177,773,650 total
· as of Mar 31, 2026
Showing 1–50
of 99 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 502,012 | $10,502,091 | 5.91% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 80,792 | $7,857,022 | 4.42% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Added | 195,685 | $7,494,735 | 4.22% | |
| LQDA |
Liquidia Corp
Healthcare
|
Added | 187,876 | $7,090,440 | 3.99% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Added | 209,547 | $7,088,975 | 3.99% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
NEW | 2,947,826 | $6,662,086 | 3.75% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Added | 164,030 | $6,429,976 | 3.62% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 108,450 | $6,302,029 | 3.54% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 149,399 | $5,750,367 | 3.23% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Reduced | 75,758 | $5,127,301 | 2.88% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Added | 172,731 | $4,879,650 | 2.74% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 43,052 | $4,793,840 | 2.70% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Added | 54,258 | $4,553,331 | 2.56% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Added | 61,269 | $4,038,239 | 2.27% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Reduced | 115,770 | $3,875,979 | 2.18% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 222,468 | $3,599,532 | 2.02% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
NEW | 128,168 | $3,550,253 | 2.00% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Added | 213,819 | $3,192,317 | 1.80% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
NEW | 433,515 | $3,138,648 | 1.77% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
NEW | 86,283 | $2,874,949 | 1.62% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 625,708 | $2,796,914 | 1.57% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 12,179 | $2,785,702 | 1.57% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 516,972 | $2,734,781 | 1.54% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
NEW | 101,248 | $2,622,323 | 1.48% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Added | 128,487 | $2,586,443 | 1.45% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Added | 257,738 | $2,564,493 | 1.44% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 14,055 | $2,375,576 | 1.34% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 99,887 | $1,887,864 | 1.06% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 69,571 | $1,884,678 | 1.06% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Added | 3,393 | $1,776,133 | 1.00% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Added | 371,398 | $1,745,570 | 0.98% | |
| LONA |
LeonaBio, Inc.
Healthcare
|
Added | 164,676 | $1,692,869 | 0.95% | |
| SVRA |
Savara Inc
Healthcare
|
Added | 295,688 | $1,614,456 | 0.91% | |
| CATX |
Perspective Therapeutics, Inc.
Healthcare
|
NEW | 379,082 | $1,580,771 | 0.89% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Reduced | 56,147 | $1,558,079 | 0.88% | |
| NERV |
Minerva Neurosciences, Inc.
Healthcare
|
NEW | 248,476 | $1,497,067 | 0.84% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
NEW | 77,858 | $1,464,508 | 0.82% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Added | 19,800 | $1,388,970 | 0.78% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
NEW | 82,890 | $1,212,680 | 0.68% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
NEW | 50,252 | $1,159,313 | 0.65% | |
| LRMR |
Larimar Therapeutics, Inc.
Healthcare
|
NEW | 256,585 | $1,154,632 | 0.65% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Added | 4,316 | $1,114,909 | 0.63% | |
| IVA |
Inventiva S.A.
Healthcare
|
NEW | 200,141 | $1,110,782 | 0.62% | |
| LPCN |
Lipocine Inc.
Healthcare
|
NEW | 124,942 | $998,286 | 0.56% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
NEW | 19,690 | $993,163 | 0.56% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
NEW | 102,493 | $975,733 | 0.55% | |
| XNCR |
Xencor Inc
Healthcare
|
Reduced | 80,000 | $964,800 | 0.54% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
NEW | 29,300 | $929,396 | 0.52% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
NEW | 120,400 | $921,060 | 0.52% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
NEW | 30,707 | $916,603 | 0.52% |